The global prevalence of latent tuberculosis: a systematic review and meta-analysis
In 1999, the World Health Organization (WHO) estimated that one-third of the world's
population had latent tuberculosis infection (LTBI), which was recently updated to one …
population had latent tuberculosis infection (LTBI), which was recently updated to one …
Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection
Tuberculosis (TB) is the leading infectious cause of mortality worldwide, due in part to a
limited understanding of its clinical pathogenic spectrum of infection and disease …
limited understanding of its clinical pathogenic spectrum of infection and disease …
ECCO guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease
T Kucharzik, P Ellul, T Greuter, JF Rahier… - Journal of Crohn's …, 2021 - academic.oup.com
The introduction and broad use of new immunosuppressive agents, including biologic
agents and JAK inhibitors, have revolutionised treatment of inflammatory bowel disease …
agents and JAK inhibitors, have revolutionised treatment of inflammatory bowel disease …
Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination
Abstract Background Recent Mycobacterium tuberculosis infection confers a predisposition
to the development of tuberculosis disease, the leading killer among global infectious …
to the development of tuberculosis disease, the leading killer among global infectious …
The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling
RMGJ Houben, PJ Dodd - PLoS medicine, 2016 - journals.plos.org
Background The existing estimate of the global burden of latent TB infection (LTBI) as “one-
third” of the world population is nearly 20 y old. Given the importance of controlling LTBI as …
third” of the world population is nearly 20 y old. Given the importance of controlling LTBI as …
Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of …
DM Lewinsohn, MK Leonard, PA LoBue… - Clinical Infectious …, 2017 - academic.oup.com
Abstract Background. Individuals infected with Mycobacterium tuberculosis (Mtb) may
develop symptoms and signs of disease (tuberculosis disease) or may have no clinical …
develop symptoms and signs of disease (tuberculosis disease) or may have no clinical …
Pathogenicity and virulence of Mycobacterium tuberculosis
Mycobacterium tuberculosis (Mtb) is the causative agent of tuberculosis, an infectious
disease with one of the highest morbidity and mortality rates worldwide. Leveraging its …
disease with one of the highest morbidity and mortality rates worldwide. Leveraging its …
Latent Mycobacterium tuberculosis Infection
H Getahun, A Matteelli, RE Chaisson… - New England Journal …, 2015 - Mass Medical Soc
Latent Mycobacterium tuberculosis Infection | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …
content The New England Journal of Medicine homepage Advanced Search SEARCH …
Advances in molecular diagnosis of tuberculosis
Molecular tests for tuberculosis (TB) have the potential to help reach the three million people
with TB who are undiagnosed or not reported each year and to improve the quality of care …
with TB who are undiagnosed or not reported each year and to improve the quality of care …
Pulmonary tuberculosis: role of radiology in diagnosis and management
AC Nachiappan, K Rahbar, X Shi, ES Guy… - Radiographics, 2017 - pubs.rsna.org
Tuberculosis is a public health problem worldwide, including in the United States—
particularly among immunocompromised patients and other high-risk groups. Tuberculosis …
particularly among immunocompromised patients and other high-risk groups. Tuberculosis …